Lungu AO - Search Results

1

Ligand-independent activation of vascular endothelial growth factor receptor 2 by fluid shear stress regulates activation of endothelial nitric oxide synthase.

Jin ZG, Ueba H, Tanimoto T, Lungu AO, Frame MD, Berk BC. Jin ZG, et al. Among authors: lungu ao. Circ Res. 2003 Aug 22;93(4):354-63. doi: 10.1161/01.RES.0000089257.94002.96. Epub 2003 Jul 31. Circ Res. 2003. PMID: 12893742

2

Sphingosine 1-phosphate transactivates the platelet-derived growth factor beta receptor and epidermal growth factor receptor in vascular smooth muscle cells.

Tanimoto T, Lungu AO, Berk BC. Tanimoto T, et al. Among authors: lungu ao. Circ Res. 2004 Apr 30;94(8):1050-8. doi: 10.1161/01.RES.0000126404.41421.BE. Epub 2004 Mar 25. Circ Res. 2004. PMID: 15044318

3

Cyclosporin A inhibits flow-mediated activation of endothelial nitric-oxide synthase by altering cholesterol content in caveolae.

Lungu AO, Jin ZG, Yamawaki H, Tanimoto T, Wong C, Berk BC. Lungu AO, et al. J Biol Chem. 2004 Nov 19;279(47):48794-800. doi: 10.1074/jbc.M313897200. Epub 2004 Sep 20. J Biol Chem. 2004. PMID: 15383526 Free article.

4

Cyclophilin A is a proinflammatory cytokine that activates endothelial cells.

Jin ZG, Lungu AO, Xie L, Wang M, Wong C, Berk BC. Jin ZG, et al. Among authors: lungu ao. Arterioscler Thromb Vasc Biol. 2004 Jul;24(7):1186-91. doi: 10.1161/01.ATV.0000130664.51010.28. Epub 2004 May 6. Arterioscler Thromb Vasc Biol. 2004. PMID: 15130913

5

Bone mineral content in patients with congenital generalized lipodystrophy is unaffected by metreleptin replacement therapy.

Christensen JD, Lungu AO, Cochran E, Collins MT, Gafni RI, Reynolds JC, Rother KI, Gorden P, Brown RJ. Christensen JD, et al. Among authors: lungu ao. J Clin Endocrinol Metab. 2014 Aug;99(8):E1493-500. doi: 10.1210/jc.2014-1353. Epub 2014 Jul 29. J Clin Endocrinol Metab. 2014. PMID: 25070319 Free PMC article. Clinical Trial.

6

The liver diseases of lipodystrophy: the long-term effect of leptin treatment.

Safar Zadeh E, Lungu AO, Cochran EK, Brown RJ, Ghany MG, Heller T, Kleiner DE, Gorden P. Safar Zadeh E, et al. Among authors: lungu ao. J Hepatol. 2013 Jul;59(1):131-7. doi: 10.1016/j.jhep.2013.02.007. Epub 2013 Feb 21. J Hepatol. 2013. PMID: 23439261 Free PMC article. Clinical Trial.

7

Insulin resistance is a sufficient basis for hyperandrogenism in lipodystrophic women with polycystic ovarian syndrome.

Lungu AO, Zadeh ES, Goodling A, Cochran E, Gorden P. Lungu AO, et al. J Clin Endocrinol Metab. 2012 Feb;97(2):563-7. doi: 10.1210/jc.2011-1896. Epub 2011 Nov 16. J Clin Endocrinol Metab. 2012. PMID: 22090274 Free PMC article. Clinical Trial.

8

Cardiomyopathy in congenital and acquired generalized lipodystrophy: a clinical assessment.

Lupsa BC, Sachdev V, Lungu AO, Rosing DR, Gorden P. Lupsa BC, et al. Among authors: lungu ao. Medicine (Baltimore). 2010 Jul;89(4):245-250. doi: 10.1097/MD.0b013e3181e9442f. Medicine (Baltimore). 2010. PMID: 20616664 Free PMC article.

9

Treatment of type B insulin resistance: a novel approach to reduce insulin receptor autoantibodies.

Malek R, Chong AY, Lupsa BC, Lungu AO, Cochran EK, Soos MA, Semple RK, Balow JE, Gorden P. Malek R, et al. Among authors: lungu ao. J Clin Endocrinol Metab. 2010 Aug;95(8):3641-7. doi: 10.1210/jc.2010-0167. Epub 2010 May 19. J Clin Endocrinol Metab. 2010. PMID: 20484479 Free PMC article.

10

Is there a human model for the 'metabolic syndrome' with a defined aetiology?

Gorden P, Lupsa BC, Chong AY, Lungu AO. Gorden P, et al. Among authors: lungu ao. Diabetologia. 2010 Jul;53(7):1534-6. doi: 10.1007/s00125-010-1719-7. Epub 2010 Apr 17. Diabetologia. 2010. PMID: 20401463 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters